Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC6A4 | P31645 | 1/20 | 0.39 |
| ▸ | HTR6 | P50406 | 1/20 | 0.39 |
| ▸ | MCHR1 | Q99705 | 2/20 | 0.37 |
| ▸ | PARP10 | Q53GL7 | 4/20 | 0.36 |
| ▸ | HTR2A | P28223 | 2/20 | 0.36 |
| ▸ | HTR2C | P28335 | 2/20 | 0.36 |
| ▸ | HTR2B | P41595 | 2/20 | 0.36 |
| ▸ | HPGD | P15428 | 3/20 | 0.36 |
| ▸ | PARP15 | Q460N3 | 3/20 | 0.36 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12366406 | 0.94 | HTR2C (0.40) | HTR2AHTR2CHTR2B | |
| SCHEMBL24170300 | 0.90 | HTR2C (0.37) | HTR2AHTR2CHTR2B | |
| SCHEMBL12366417 | 0.90 | HTR2C (0.37) | HTR2AHTR2CHTR2B | |
| SCHEMBL1512804 | 0.88 | HTR2C (0.42) | SLC6A4HTR6HTR2AHTR2CHTR2B | |
| SCHEMBL26036401 | 0.88 | HTR2C (0.36) | HTR2AHTR2CHTR2B | |
| SCHEMBL1512802 | 0.88 | HTR2C (0.42) | SLC6A4HTR6HTR2AHTR2CHTR2B | |
| SCHEMBL1853162 | 0.88 | HTR2C (0.36) | HTR2AHTR2CHTR2B | |
| SCHEMBL1853160 | 0.88 | HTR2C (0.36) | HTR2AHTR2CHTR2B | |
| SCHEMBL15727962 | 0.87 | HPGD (0.39) | HTR2AHTR2CHTR2BHPGD | |
| SCHEMBL2266958 | 0.87 | HTR2C (0.36) | HTR2AHTR2CHTR2B |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 16 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11873438-B2 | Liquid-crystal medium | MERCK PATENT GMBH (DE) | 2024-01-16 | — | — | US | disclosed |
| US-11739266-B2 | Polymerisable compounds and the use thereof in liquid-crystal displays | MERCK PATENT GMBH (DE) | 2023-08-29 | — | — | US | disclosed |
| US-20230007940-A1 | LIQUID-CRYSTAL MEDIUM COMPRISING POLYMERISABLE COMPOUNDS AND THE USE THEREOF IN LIQUID-CRYSTAL DISPLAYS | MERCKP PATENT GMBH (DE) | 2023-01-12 | — | — | US | disclosed |
| US-20230002678-A1 | POLYMERISABLE COMPOUNDS AND THE USE THEREOF IN LIQUID-CRYSTAL DISPLAYS | MERCK PATENT GMBH (DE) | 2023-01-05 | — | — | US | disclosed |
| US-11214736-B2 | Liquid-crystalline medium | MERCK PATENT GMBH (DE) | 2022-01-04 | — | — | US | disclosed |
| US-20210222067-A1 | LIQUID-CRYSTAL MEDIUM | MERCK PATENT GMBH (DE) | 2021-07-22 | — | — | US | disclosed |
| US-10934487-B2 | Liquid crystalline medium | MERCK PATENT GMBH (DE) | 2021-03-02 | — | — | US | disclosed |
| US-10894918-B2 | Liquid crystal medium containing polymerisable compounds | MERCK PATENT GMBH (DE) | 2021-01-19 | — | — | US | disclosed |
| US-10759996-B2 | Liquid-crystal medium | MERCK PATENT GMBH (DE) | 2020-09-01 | — | — | US | disclosed |
| US-20190345389-A1 | LIQUID-CRYSTALLINE MEDIUM | MERCK PATENT GMBH (DE) | 2019-11-14 | — | — | US | disclosed |
| US-20190316037-A1 | LIQUID-CRYSTALLINE MEDIUM | MERCK PATENT GMBH (DE) | 2019-10-17 | — | — | US | disclosed |
| US-10400169-B2 | Liquid-crystalline medium | MERCK PATENT GMBH (DE) | 2019-09-03 | — | — | US | disclosed |
| US-20190264105-A1 | LIQUID-CRYSTAL MEDIUM | MERCK PATENT GMBH (DE) | 2019-08-29 | — | — | US | disclosed |
| US-20180171231-A1 | LIQUID-CRYSTALLINE MEDIUM | MERCK PATENT GMBH (DE) | 2018-06-21 | — | — | US | disclosed |
| US-9944416-B2 | Filling device and use thereof for dispensing a fluid | MERCK PATENT GMBH (DE) | 2018-04-17 | — | — | US | disclosed |
| US-20170044438-A1 | LIQUID-CRYSTALLINE MEDIUM | MERCK PATENT GMBH (DE) | 2017-02-16 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170044438-A1 | LIQUID-CRYSTALLINE MEDIUM | VIM, COL2A1, COL1A1 | SLC6A4 3961/4885HTR6 1887/4885MCHR1 4265/4885 |
| US-10400169-B2 | Liquid-crystalline medium | VIM, COL2A1, COL1A1 | SLC6A4 3961/4885HTR6 1887/4885MCHR1 4265/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.